Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: Data from Italian ICD registry for the years 2001-6

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 4, 2009, Pages 434-445

  Proclemer, Alessandro ^a   Ghidina, Marco ^a   Facchin, Domenico ^a   Rebellato, Luca ^a   Corrado, Domenico ^b   Gasparini, Maurizio ^c   Gregori, Dario ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Implantable cardioverter defibrillator; Inherited arrhythmia syndromes; Registry; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; BRUGADA SYNDROME; CLINICAL STUDY; CONTROLLED STUDY; DEFIBRILLATOR; DEMOGRAPHY; ELECTROCARDIOGRAPHY; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; SHORT QT SYNDROME;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 63049100936     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02302.x     Document Type: Article

References (54)

1. Boriani G, Rapezzi C, Biffi M, Branzi A. Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant. Int J Cardiol 2002 83 : 171 173.
2. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, et al. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000 36 : 2212 2218.
3. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000 342 : 365 373.
4. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007 298 : 405 412.
5. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003 108 : 3084 3091.
6. Link MS, Wang PJ, Haugh CJ, Homoud MK, Foote CB, Costeas XB, Estes NA. Arrhythmogenic right ventricular dysplasia: Clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol 1997 1 : 41 48.
7. Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, et al. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2005 2 : 1188 1194.
8. Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004 43 : 1843 1852.
9. Tavernier R, Gevaert S, De Sutter J, De Clercq A, Rottiers H, Jordaens L, Fonteyne W. Long-term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2004 85 : 53 56.
10. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients. Circulation 2004 109 : 1503 1508.
11. Goel AK, Berger S, Pelech A, Dhala A. Implantable cardioverter defibrillator therapy in children with long QT syndrome. Pediatr Cardiol 2004 25 : 370 378.
12. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996 78 : 703 706.
13. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004 27 : 924 932.
14. Monnig G, Kobe J, Loher A, Eckardt L, Wedekind H, Scheld HH, Haverkamp W, et al. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: A long-term follow-up. Heart Rhythm 2005 2 : 497 504.
15. Silka MJ, Kron J, Dunnigan A, Dick M. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients: The pediatric electrophysiology society. Circulation 1993 87 : 800 807.
16. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003 14 : 337 341.
17. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998 392 : 293 296.
18. Chugh SS, Kelly KL, Titus JL. Sudden cardiac death with apparently normal heart. Circulation 2000 102 : 649 654.
19. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, et al. Brugada syndrome: Report of the second consensus conference. Circulation 2005 11 : 659 670.
20. Brugada P, Brugada R, Brugada J, Geelen P. Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts. Am J Cardiol 1999 83 : 98D 100D.
21. Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 2001 103 : 710 717.
22. Kakishita M, Kurita T, Matsuo K, Taguchi A, Suyama K, Shimizu W, Aihara N, et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000 36 : 1646 1653.
23. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F, Mabo P, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: A multicenter study. Circulation 2006 114 : 2317 2324.
24. Boriani G, Biffi M, Valzania C, Bronzetti G, Martignani C. Short QT syndrome and arrhythmogenic cardiac diseases in the young: The challenge of implantable cardioverter-defibrillator therapy for children. Eur Heart J 2006 27 : 2382 2384.
25. Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbragia P, Leone G, et al. Short QT syndrome: Clinical findings and diagnostic-therapeutic implications. Eur Heart J 2006 27 : 2440 2447.
26. Schimpf R, Bauersfeld U, Gaita F, Wolpert C. Short QT syndrome: Successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2005 2 : 416 417.
27. Hasdemir C, Priori SG, Overholt E, Lazzara R. Catecholaminergic polymorphic ventricular tachycardia, recurrent syncope, and implantable loop recorder. J Cardiovasc Electrophysiol 2004 15 : 729.
28. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: A 7-year follow-up of 21 patients. Circulation 1995 91 : 1512 1519.
29. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002 106 : 69 74.
30. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002 106 : 2145 2161.
31. Hauer RN, Aliot E, Block M, Capucci A, Luderitz B, Santini M, Vardas PE. for the European Society of Cardiology. Working Group on Arrhythmias and Working Group on Cardiac Pacing of the European Society of Cardiology. Indications for implantable cardioverter defibrillator (ICD) therapy: Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Eur Heart J 2001 22 : 1074 1081.
32. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001 22 : 1374 1450.
33. Priori SG, Barhanin J, Hauer RN, Haverkamp W, Jongsma HJ, Kleber AG, McKenna WJ, et al. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management parts I and II. Circulation 1999 99 : 518 528.
34. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 : e385 484.
35. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, et al. for the Task Force on Clinical Expert Consensus Documents, American College of Cardiology; Committee for Practice Guidelines, European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003 42 : 1687 1713.
36. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994 71 : 215 218.
37. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III., Freedman RA, Gettes LS, Gillinov AM, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 2008 51 : 1 62.
38. Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM. Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy. A survey of the national activity during the years 2001-2004. Pacing Clin Electrophysiol 2006 29 : S20 S28.
39. R Development Core Team. R: A Language and Environment for Statistical Computing, Vienna, Austria, 2008.
40. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 1999 341 : 1882 1890.
41. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996 335 : 1933 1940.
42. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
43. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
44. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
45. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000 101 : 1297 1302.
46. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 351 : 2151 2158.
47. Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000 102 : 748 754.
48. The Antiarrhythmics Versus Implantable Defibrillator (AVID). Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997 337 : 1576 1583.
49. Cannom DS, Prystowsky EN. The evolution of the implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004 27 : 419 431.
50. Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich P, Lindsay BD, Mirro MJ, et al. Review of the registry's first year, data collected, and future plans. Heart Rhythm 2007 4 : 1260 1263.
51. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001 103 : 196 200.
52. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Sassone B, et al. PRELUDE Registry. 2007. Available at http://www.spo. escardio.org/CongressPresentations/ESC2007/4244/priori-4244-esc2007-slides.pdf accessed 5/12/08 I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S, Zareba W, et al. Long-QT syndrome after age 40. Circulation 2008 117 : 2192 2201.
53. Goldenberg I, Moss AJ, Zareba W, McNitt S, Robinson JL, Qi M, Towbin JA, et al. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol 2006 17 : 1161 1168.
54. Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, Shkolnikova M, et al. The Jervell and Lange-Nielsen syndrome: Natural history, molecular basis, and clinical outcome. Circulation 2006 113 : 783 790.